angiotensin ii has been researched along with Cardio-Renal Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filippatos, G; Mancia, G; Manolis, A; Marathias, KP; Papademetriou, V; Tsioufis, C; Vlahakos, DV | 1 |
| Bu, X; Duan, X; He, Y; Hu, H; Liu, H; Ming, X; Sun, S; Wu, Q; Yan, F; Zhu, H | 1 |
| Becirovic-Agic, M; Ericsson, M; Hultström, M; Jönsson, S; Karlsen, TV; Leh, S; Lidén, Å; Nilsson, SK; Reed, RK; Skogstrand, T; Tveitarås, MK | 1 |
| Bahl, A; Dhandapany, PS; Khullar, M; Kumar, A; Mittal, A; Prasad, R; Rana, S; Raut, SK; Saikia, UN; Sarkar, S; Sharma, R | 1 |
| Nistala, R; Whaley-Connell, A | 1 |
| Abraham, NG; Boldrin, M; Fedorova, L; Kappas, A; Monu, SR; Pesce, P; Peterson, SJ; Puri, N; Sacerdoti, D; Sodhi, K | 1 |
| Chen, J; Hu, YJ; Peng, DF; Tang, SY | 1 |
| Cai, Q; Chen, J; Huang, H; Liu, X; Liu, Y; Wang, J; Zhang, K | 1 |
| Re, RN | 2 |
| D'Elia, E; Emdin, M; Senni, M; Vergaro, G | 1 |
5 review(s) available for angiotensin ii and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia: a double-edged sword.
Topics: Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardio-Renal Syndrome; Glomerular Filtration Rate; Heart Failure; Humans; Renin-Angiotensin System | 2019 |
Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.
Topics: Albuminuria; Angiotensin II; Animals; Cardio-Renal Syndrome; Humans; Insulin Resistance; Kidney Glomerulus; Metabolic Syndrome; Signal Transduction | 2013 |
An Expanded View of Progressive Cardiorenal Disorders.
Topics: Angiotensin II; Angiotensinogen; Cardio-Renal Syndrome; Disease Progression; Heart Failure; Humans; Parathyroid Hormone-Related Protein; Peptidyl-Dipeptidase A; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2016 |
A Reassessment of the Pathophysiology of Progressive Cardiorenal Disorders.
Topics: Angiotensin II; Cardio-Renal Syndrome; Diabetic Nephropathies; Disease Progression; Humans; Intercellular Signaling Peptides and Proteins; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction | 2017 |
Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.
Topics: Adrenomedullin; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; beta-N-Acetyl-Galactosaminidase; Biomarkers; C-Reactive Protein; Cardio-Renal Syndrome; Catecholamines; Chromogranin A; Creatinine; Galectin 3; Glycopeptides; Growth Differentiation Factor 15; Heart Failure; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-1; Interleukin-1 Receptor-Like 1 Protein; Interleukin-18; Interleukin-6; Lipocalin-2; MicroRNAs; Natriuretic Peptide, Brain; Peptide Fragments; Renin; Renin-Angiotensin System; Stroke Volume; Troponin; Troponin T; Tumor Necrosis Factor-alpha | 2017 |
6 other study(ies) available for angiotensin ii and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
Topics: Albuminuria; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cardio-Renal Syndrome; Creatinine; Cystatin C; Drugs, Chinese Herbal; Interleukin-6; Kidney; Male; Myocardial Infarction; NADPH Oxidase 2; Natriuretic Peptide, Brain; Oxidative Stress; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
Time course of decompensation after angiotensin II and high-salt diet in Balb/CJ mice suggests pulmonary hypertension-induced cardiorenal syndrome.
Topics: Angiotensin II; Animals; Blood Pressure; Cardio-Renal Syndrome; Diet; Heart Failure; Hypertension; Hypertension, Pulmonary; Male; Mice, Inbred BALB C; Myocardium; Sodium Chloride, Dietary; Time Factors; Water-Electrolyte Imbalance | 2019 |
Myocardin ablation in a cardiac-renal rat model.
Topics: Angiotensin II; Animals; Cardio-Renal Syndrome; Cardiomyopathy, Dilated; Collagen Type I; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Ventricles; Male; Myocytes, Cardiac; Nuclear Proteins; Rats; RNA Interference; RNA, Small Interfering; Trans-Activators; Transforming Growth Factor beta; Ventricular Function | 2019 |
HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation.
Topics: Angiotensin II; Animals; Body Weight; Cardio-Renal Syndrome; Creatinine; Echocardiography; Enzyme Induction; Heme Oxygenase-1; Kidney; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Renin | 2013 |
Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats.
Topics: Angiotensin II; Animals; Atorvastatin; Benzazepines; C-Reactive Protein; Cardio-Renal Syndrome; Case-Control Studies; Drug Synergism; Heptanoic Acids; Lipids; Male; Natriuretic Peptide, Brain; Proteinuria; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2015 |
Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Acetophenones; Aged; Angiotensin II; Animals; Cardio-Renal Syndrome; Cardiotonic Agents; Cell Line; Disease Models, Animal; Epoxide Hydrolases; Female; Fibrosis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocytes, Cardiac; Rats, Sprague-Dawley; Stroke Volume; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2015 |